Business Segments Virbac Deutsche Boerse AG

Stocks

V16

FR0000031577

Pharmaceuticals

Market Closed - Deutsche Boerse AG 09:25:02 2026-09-01 EDT			After hours 15:59:00
320.50 ^EUR	+0.16%		321.25	+0.23%

08-20	Cancer vaccines finally garner the spotlight
07-29	Virbac, without the alibi

Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (EUR)

Fiscal Period: December	2021	2022	2023	2024	2025
Veterinary Drugs
Companion Animals	609M	706M	721M	824M	869M
	-	-	-	-	575M
Farm Animals	426M	478M	493M	537M	575M
	-	-	-	-	869M
Pharmaceutical Contract Manufacturing Services
Other Businesses	28.8M	31.8M	33.2M	36.3M	20.3M
	-	-	-	-	20.3M

Geographical breakdown of sales (EUR)

Fiscal Period: December	2021	2022	2023	2024	2025
Europe	-	-	-	571M	610M
Total Assets	-	-	-	565M	794M
D&A	-	-	-	-	26.49M
CAPEX	-	-	-	-49.09M	-64.33M
Net Income	-	-	-	61.16M	63.77M
Operating Income	-	-	-	90.99M	89.84M
	-	-	-	-	154M
Latin America	167M	197M	214M	222M	223M
Total Assets	205M	272M	280M	272M	262M
D&A	-	-	-	-	7.76M
CAPEX	-3.17M	-4.21M	-4.24M	-5.36M	-4.23M
Net Income	15.87M	13.17M	9.68M	19.78M	18.07M
Operating Income	34.78M	33.64M	31.52M	37.96M	34.54M
North America	124M	162M	165M	182M	200M
Total Assets	-132M	231M	220M	249M	209M
D&A	-	-	-	-	7.44M
CAPEX	-7.63M	-9.7M	-5.46M	-11.12M	-8.64M
Net Income	-9.14M	-6.03M	-10.13M	2.06M	-1.64M
Operating Income	-6.97M	-3.97M	-5.57M	4.85M	4.64M
	-	-	-	-	101M
India, Africa and Middle East ("IMEA")	-	-	-	174M	178M
Total Assets	-	-	-	172M	131M
D&A	-	-	-	-	3.1M
CAPEX	-	-	-	-1.02M	-2.24M
Net Income	-	-	-	40.04M	41.32M
Operating Income	-	-	-	52.13M	54.68M
Far East Asia	-	-	-	141M	154M
Total Assets	-	-	-	467M	407M
D&A	-	-	-	-	11.6M
CAPEX	-	-	-	-3.28M	-3.89M
Net Income	-	-	-	2.75M	9.4M
Operating Income	-	-	-	15.46M	17.83M
	-	-	-	-	178M
Pacific	94.19M	118M	116M	108M	101M
Total Assets	111M	130M	129M	124M	111M
D&A	-	-	-	-	3.46M
CAPEX	-1.11M	-2.08M	-3.59M	-4.97M	-1.55M
Net Income	17.66M	24.36M	26.9M	19.5M	19.98M
Operating Income	26.24M	35.74M	39.16M	30.43M	28.13M
	-	-	-	-	223M
Africa & Middle East	29.7M	32.47M	29.67M	-	-
Total Assets	11.15M	15.73M	15.99M	-	-
CAPEX	-110K	-275K	-234K	-	-
Net Income	3.24M	2.98M	2.55M	-	-
Operating Income	4.72M	4.3M	3.48M	-	-
	-	-	-	-	610M
Europe (Excluding france)	281M	303M	327M	-	-
Total Assets	62.52M	100M	131M	-	-
CAPEX	-578K	-1.01M	-545K	-	-
Net Income	16.41M	21.76M	24.07M	-	-
Operating Income	22.88M	28.85M	32.4M	-	-
Asia	184M	213M	204M	-	-
Total Assets	186M	244M	293M	-	-
CAPEX	-8.01M	-3.67M	-2.94M	-	-
Net Income	28.58M	31.12M	34.91M	-	-
Operating Income	37.04M	40.89M	42.04M	-	-
France	185M	192M	192M	-	-
Total Assets	757M	341M	387M	-	-
CAPEX	-28.51M	-34.98M	-29.36M	-	-
Net Income	40.55M	34.61M	33.32M	-	-
Operating Income	54.48M	47.12M	45.12M	-	-
	-	-	-	-	200M